Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $108.80 | Total: $544.00 |
| 1 | 10 | $92.16 | Total: $921.60 |
| 1 | 25 | $78.08 | Total: $1,952.00 |
| 1 | 50 | $66.56 | Total: $3,328.00 |
| 1 | 100 | $57.60 | Total: $5,760.00 |
Overview
NUCC-390, a novel small-molecule CXCR4 receptor agonist, selectively induces CXCR4 receptor internalization while acting antagonistically to AMD3100. This compound facilitates nerve functional recovery following neurodegeneration in vivo.
Chemical Properties
| Molecular Formula | C23H33N5O |
| Molecular Weight | 395.54 |
| CAS Numbers | 1060524-97-1 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(=O)(C=1C2=C(N(CCC)N1)CCC(NCCC=3C=CN=CC3)C2)N4CCCCC4 |
Storage and Handling
0C Short Term, -20C Long Term
References
Mishra RK, et al. Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists.Sci Rep. 2016 Jul 26;6 30155.